Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death (Q45880909)

17 December 2017

title

Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death (English)

1 reference

17 December 2017

0 references

4

1 reference

17 December 2017

author name string

Sandig V

1

1 reference

17 December 2017

Brand K

2

1 reference

17 December 2017

Herwig S

3

1 reference

17 December 2017

Bartek J

5

1 reference

17 December 2017

Strauss M

6

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

17 December 2017

published in

Nature Medicine

1 reference

17 December 2017

volume

3

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

313-319

1 reference

17 December 2017

Gene therapy: adenovirus vectors.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

Cyclin D1 as a cellular proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

p53 in signaling checkpoint arrest or apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for interleukin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Gene therapy of cancer through restoration of tumor-suppressor functions?

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

The basic science of gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Adenovirus and adeno-associated virus mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Unrestricted cell cycling and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Mutations and altered expression of p16INK4 in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Life, death, and the pursuit of apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Inhibition of apoptosis by the retinoblastoma gene product.

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

E2F: a link between the Rb tumor suppressor protein and viral oncoproteins

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

p53 and E2F-1 cooperate to mediate apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

A novel form of Epstein-Barr virus latency in normal B cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

A simple and efficient method for purification of infectious recombinant adenovirus.

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Estimation of liver tumor volume using different formulas - an experimental study in rats

1 reference

https://api.crossref.org/works/10.1038%2FNM0397-313

7 January 2021

Identifiers

DOI

10.1038/NM0397-313

1 reference

17 December 2017

Dimensions Publication ID

1034212204

0 references

1 reference

17 December 2017